Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Oppenheimer Sticks to Their Buy Rating for Community Health (CYH)

Tipranks - Tipranks - Fri Feb 20, 7:32AM CST

In a report released today, Michael Wiederhorn from Oppenheimer maintained a Buy rating on Community Health, with a price target of $4.00.

President's Day Sale - 70% Off

According to TipRanks, Wiederhorn is a 5-star analyst with an average return of 9.7% and a 58.92% success rate. Wiederhorn covers the Healthcare sector, focusing on stocks such as The Ensign Group, Amedisys, and Centene.

In addition to Oppenheimer, Community Health also received a Buy from RBC Capital’s Ben Hendrix in a report issued on February 17. However, today, Barclays maintained a Hold rating on Community Health (NYSE: CYH).

See today’s best-performing stocks on TipRanks >>

Based on Community Health’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $3.11 billion and a net profit of $110 million. In comparison, last year the company earned a revenue of $3.27 billion and had a GAAP net loss of $70 million

Read More on CYH:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).